Cumulative evidence has indicated that ER stress, especially GRP78, which is a downstream target of ATF6, was correlated with chemotherapy resistance in cancer cells (Garg et al., 2015; Kim et al., 2016; Wang and Kaufman, 2014). Here, ATF6 is linked to cancer.